ANDA 86666, held by Bel Mar. Methylprednisolone Acetate.
As of Nov 21, 2026, ANDA 86666 (M-Predrol), held by Bel Mar, was first approved by FDA on Dec 6, 1979, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 6, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| M-Predrol40MG/ML · injectable;injection | Methylprednisolone Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters